Literature DB >> 23153330

Conjugation of quinones with natural polyamines: toward an expanded antitrypanosomatid profile.

Federica Lizzi1, Giacomo Veronesi, Federica Belluti, Christian Bergamini, Almudena López-Sánchez, Marcel Kaiser, Reto Brun, R Luise Krauth-Siegel, Dennis G Hall, Luis Rivas, Maria Laura Bolognesi.   

Abstract

A combinatorial library of quinone-polyamine conjugates designed to optimize the antitrypanosomatid profile of hit compounds 1 and 2 has been prepared by a solid-phase approach. The conjugates were evaluated against the three most important human trypanosomatid pathogens (Trypanosoma brucei rhodesiense, Trypanosoma cruzi, and Leishmania donovani), and several showed promising activity. A subset also inhibited trypanothione reductase in vitro and induced oxidase activity of the enzyme. A highly potent analogue (7) was identified with activity against T. brucei as low as 70 nM and a selectivity index of 72. Interestingly, the presence of a cadaverine tail confers to 7 the ability to target mitochondrial function in Leishmania. In fact, in L. donovani promastigotes, we verified for 7 a decrease of cytoplasmic ATP and mitochondrial potential. Therefore, the current results support the suitability of the conjugation approach for the development of novel polyamine conjugates with enhanced therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23153330     DOI: 10.1021/jm301112z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

Review 1.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

2.  Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning.

Authors:  Lucas N Alberca; María L Sbaraglini; Darío Balcazar; Laura Fraccaroli; Carolina Carrillo; Andrea Medeiros; Diego Benitez; Marcelo Comini; Alan Talevi
Journal:  J Comput Aided Mol Des       Date:  2016-02-18       Impact factor: 3.686

3.  Naphthoquinone as a New Chemical Scaffold for Leishmanicidal Inhibitors of Leishmania GSK-3.

Authors:  Victor Sebastián-Pérez; Paula Martínez de Iturrate; Montserrat Nácher-Vázquez; Luis Nóvoa; Concepción Pérez; Nuria E Campillo; Carmen Gil; Luis Rivas
Journal:  Biomedicines       Date:  2022-05-14

4.  Quinone-amino acid conjugates targeting Leishmania amino acid transporters.

Authors:  Federica Prati; Adele Goldman-Pinkovich; Federica Lizzi; Federica Belluti; Roni Koren; Dan Zilberstein; Maria Laura Bolognesi
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

Review 5.  Use of Natural Products in Leishmaniasis Chemotherapy: An Overview.

Authors:  Luiza F O Gervazoni; Gabrielle B Barcellos; Taiana Ferreira-Paes; Elmo E Almeida-Amaral
Journal:  Front Chem       Date:  2020-11-23       Impact factor: 5.221

Review 6.  Recent Advances in the Synthesis of Polyamine Derivatives and Their Applications.

Authors:  Artemiy Nichugovskiy; Gian Cesare Tron; Mikhail Maslov
Journal:  Molecules       Date:  2021-10-30       Impact factor: 4.411

7.  Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl-, and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agents.

Authors:  Irene Sola; Albert Artigas; Martin C Taylor; F Javier Pérez-Areales; Elisabet Viayna; M Victòria Clos; Belén Pérez; Colin W Wright; John M Kelly; Diego Muñoz-Torrero
Journal:  Bioorg Med Chem       Date:  2016-08-22       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.